Birmingham, West Midlands -- (SBWIRE) -- 07/26/2013 -- Value Penny Stocks issues special report on: Sequenom, Inc. (NASDAQ:SQNM), Gilead Sciences, Inc. (NASDAQ:GILD), Inovio Pharmaceuticals Inc (NYSEMKT:INO), AEterna Zentaris Inc. (USA) (NASDAQ:AEZS).
Sequenom, Inc. (NASDAQ:SQNM) ended lower -29.64% and complete the day at $3.30. The total number of shares changed hands during the day was 32.95 million. After opening at $3.07, the stock hit as high as $3.42. However, it traded between $2.65 and $5.36 over the last twelve months.
Manufactures DNA detection and sequencing equipment. The Company's two business units combine to utilize their MassARRAY system, SNP assay portfolio, disease gene discovery programs and DNA sample repository. Sequenom provides genetic analysis products that translate genomic science into solutions for biomedical research, molecular medicine and agricultural applications
Has SQNM Found The Bottom and Ready To Move Up? Find Out Here
Gilead Sciences, Inc. (NASDAQ:GILD) closed yesterday at $60.86, a +1.64% increase. Around 11.35 million shares were traded, beating an-average trading volume of 9.74 million shares. The company is now valued at around $92.83 billion.
Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead’s primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions.
For How Long GILD Gloss will Attract Investors? Find out via this report
Inovio Pharmaceuticals Inc (NYSEMKT:INO) moved +7.19 percent higher at $1.49 and traded between $1.40 and $1.50 after opening the day at $1.40. Its performance over the last five days remained 19.20%, which stands at 112.86% for a month. Going back further than one month, 1-year performance after recent close was 198.00%.
Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens
+For How Long INO Gloss will Attract Investors? Find out via this report
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares fall, losing -20.90 percent to close at $1.40. The stock is low around -41.18% this year and -45.74% for the last 12 months. Around 6.21 million shares changed hands yesterday, lower from an-average trading volume of 150,778 shares.
-Will AEZS Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)